ʻElua wale nō amino acids ka lōʻihi, ʻO Vilon ka peptide pōkole loa i ʻike ʻia he hana olaola. Hōʻike ka noiʻi ʻana he hopena anti-kahiko ikaika ʻo Vilon a he mea hoʻoponopono ikaika ia o ka hana pale. Aia kekahi hōʻike maikaʻi e kōkua ʻo Vilon i ka hoʻoponopono ʻana i ka ʻōnaehana vascular a hoʻoikaika i ka hemostasis. Ua hōʻike ʻia ʻo Vilon e hōʻemi i ka ulu ʻana a me ka ulu ʻana o nā maʻi maʻi maʻamau, ʻoiai kona kuleana ma ke ʻano he adjuvant i ka mālama ʻana i ka maʻi kanesa (kūʻē i ka pale ʻana) ua ninauia. holookoa, He mau kākoʻo koʻikoʻi ko Vilon, e like me Dr. ʻO Vladimir Anisimov, Manaʻo ka peptide he mea hana geroprotective pono.
Kaʻina
Lysylglutamate, normophthal, Lyslglutamic acid
Helu CAS
45234-02-4
ʻĀpana Molekala
C176H277N57O55S7
Kaumaha Molekala
257.30
ʻO ka noiʻi pili Vilon
ʻO ka noiʻi mai Rūsia e hōʻike ana he mea hoʻoponopono ikaika ʻo Vilon i ka hoʻolālā chromatin. Ua ʻike ʻia kahi noiʻi ʻo Vilon:
• hoʻoulu i ka wehe ʻana o ka chromatin,
• ho'āla i nā kaʻina hana synthetic ma o ka hoʻāla hou ʻana o nā genes ribosomal i loko o ka chromatin i wehe ʻole ʻia,
• hoʻokuʻu i nā genes paʻa, a
• ʻaʻole ia e hoʻoheheʻe i ka chromatin structural pericentromeric[1].hoʻomaka ka wehe ʻana o ka chromatin,
ʻO ka hopena hopena o nā hoʻololi a Vilon i hana ai i ka DNA ʻo ka hoʻāla hou ʻana o nā ʻano genes i hoʻopaʻa ʻole ʻia. Laulaha, Loaʻa ka chromatin ma ka ʻeha (heterochromatin) a wehe ʻia paha (euchromatin) mokuʻāina. ʻAʻole hiki ke kiʻi ʻia ka heterochromatin e ka mea hana e hoʻohuli i nā genes i mau protein a no laila nā mea hana o ke kelepona.. ʻAʻole hiki ke loaʻa nā genes i kēia mau ʻāpana o ka DNA no ka hana protein.
Laulaha, Kōkua ka chromatin i ka hoʻoponopono ʻana i nā genes i loaʻa no ka unuhi ʻana a no laila ʻo ia kahi ala e hiki ai i nā cell-cell ke loaʻa nā hana like ʻole a i ʻole nā cell like ʻole ke hana like ʻole i ka manawa.. Minamina, ʻO ka condensation chromatin kekahi mea i loaʻa ma muli o ka ʻelemakule a me ka ʻelemakule a ʻo ia hoʻokahi kumu kumu e nalowale ai kā mākou mau cell a me nā ʻiʻo i ka hana ʻana i ko mākou ʻelemakule..
E like me kāna hana i loko o nā lymphocytes, Ua hōʻike ʻia ʻo Vilon e hoʻāla i ka interluekin-2 hōʻailona i loko o nā cell o ka spleen[3]. He mea koʻikoʻi ka Interleukin-2 i ka hoʻonohonoho ʻana i ka pane kūlohelohe i ka maʻi microbial a kōkua i ka pale ʻana i nā hopena autoimmune.. Ma ka hoʻoulu ʻana i nā lymphocytes a me nā splenocytes ʻoiai e hoʻonui ana i ka pale kūlohelohe i nā hopena autoimmune, Hoʻihoʻi ʻo Vilon i ka ʻōnaehana pale i kahi kūlana ʻoi aku ka ikaika a hiki ke hoʻohana i ka hoʻomohala ʻana i nā lāʻau lapaʻau no nā maʻi autoimmune..
ʻO ka hoʻohui ʻana i kona hiki ke pale i nā hopena autoimmune ke kuleana o Vilon i ka thymus. Hōʻike ka noiʻi ʻana i nā moʻomeheu thymus e hoʻonui ʻo Vilon i ka hoʻonui ʻana o nā CD5 T-cell. ʻO CD5 kahi hōʻailona o nā pūnaewele T-kōkua oʻo a me nā pūnaeau T CD8 cytotoxic. Kōkua ka mea mua i ka hoʻoponopono ʻana i ka ʻōnaehana pale a pale i nā hopena autoimmune, ʻoiai ʻo ka mea hope kekahi o nā pūnana anti-microbial ikaika loa i loko o ke kino[4].
ʻO ka hoihoi, ʻIke ʻia ʻo Vilon e hoʻāla hou i nā hana immune ma o nā genes i hoʻopau ʻia e nā loli i ka chromatin. ʻAʻole ʻike ʻia e hoʻāla i nā ʻano genes e hāmau maoli i loko o nā cell e pili ana. ʻO ia hoʻi, ʻAʻole hoʻololi ʻo Vilon i nā lymphocytes i neurons ma o ka hoʻāla ʻana i nā genes i hana maʻamau ʻole i nā lymphocytes olakino.. aka, ʻIke ʻia ka peptide e hoʻoikaika i ka hana i loko o ka ʻōnaehana pale ʻoiai e kōkua pū ana i ka pale ʻana i nā hopena autoimmune.
Vilon a me ka maʻi maʻi
E like me ka mea i kuhikuhi ʻia ma luna, Kōkua ʻo Vilon i ka hōʻemi ʻana i ka maʻi maʻi maʻi i nā kiʻi ʻiole, ʻo ia ma kahi liʻiliʻi hoʻokahi ala e hoʻolōʻihi ai i ke ola maʻamau. Hōʻike nā noiʻi hou aʻe ʻaʻole pale wale ʻo Vilon i nā ʻōpū mai ka hana ʻana, aka, keakea nei i ko lakou ulu ana ma hope o ko lakou noho ana[5]. Hōʻike kēia he ʻano chemotherapeutic maikaʻi ʻo Vilon i kāna pono ponoʻī, a me kahi mea hoʻohui kūpono i nā lāʻau lapaʻau e kū nei. I ka wā e hiki mai ana, He mea hoʻohui maʻamau ʻo Vilon i nā mea āpau mai ka chemotherapy a hiki i ka mālama ʻana i ka radiation a me ke ʻoki.
Hoʻokahi haʻawina, mai Rusia mai, kū'ē i ka ʻōlelo ʻana he kōkua pono ʻo Vilon i ka chemotherapy. Hōʻike nā hana i ka pilikia o ka hui pū ʻana o Vilon a me platinum-based chemotherapeutic agents ma mua o ka synergistic.[6]. Minamina, Ua hoʻohana kēia haʻawina i hoʻokahi wale nō ʻano o ka chemotherapy a ua kaupalena ʻia ka laulā, no laila ʻaʻole hiki ke hoʻonui ʻia nā hopena. Ke ʻike ʻia nei inā ʻoi aku ka maikaʻi o Vilon i ka maʻi kanesa ma kāna iho a inā hiki ke hoʻohui ʻia ka peptide i nā regimens lapaʻau ʻē aʻe e hoʻonui i nā hopena..
Vilon a me ka ʻelemakule
Hōʻike ka noiʻi i nā ʻiole e hoʻonui ka hoʻokele subcutaneous o Vilon i ka hoʻoikaika kino a me ka hoʻomanawanui ʻoiai e kōkua ana e hōʻemi i ka hopena o ka maʻi kanesa.. ʻO kēia mau hopena ʻelua i hopena i ka lōʻihi o ke ola o nā ʻiole i mālama ʻia, e manaʻo ana he peptide anti-aging kūpono ʻo Vilon[7]. He mea hoʻoikaika nui kēia no ka loaʻa ʻole o nā hopena ʻino i nā ʻiole ma hope o ka hoʻokele lōʻihi.
ʻO ka hoihoi, hōʻike ka noiʻi i ka Vilon mua i lawelawe ʻia, ʻoi aku ka nui o kāna mau hopena. ʻO ia hoʻi, ʻO ka hāʻawi ʻana iā Vilon i nā ʻiole ʻōpio e hoʻonui i ke ola ma mua o ka lawelawe ʻole ʻia ʻana o Vilon a ʻoi aku ka nui o nā ʻiole.. Ua ʻike ʻia kēia hopena like i nā haʻawina mua e nānā ana i nā ʻāpana thymic a me nā pineal i hāʻawi ʻia i nā ʻiole e hoʻolōʻihi i ka ʻelemakule.[8]. ʻO ka manaʻo kuhi ʻo Vilon a me nā peptides like, ke lawelawe ʻia ma hope o ke ola, hiki ke hoʻohuli i ka senescence i loko o nā pūnaewele i kēia manawa akā ʻaʻole hiki ke hana i kekahi mea no nā cell i hoʻopau ʻia ma o apoptosis.. Ma ka lawelawe ʻana iā Vilon 20mg i ka wā mua o ke ola, loaʻa i nā cell ka nui o ka pale a no laila ua lohi ka huli ʻana. ʻO ka hopena, ʻoi aku ka nui o nā cell e noho olakino no nā manawa lōʻihi, e hoʻolohi i ka pono e pani iā lākou a mālama i nā laina pūlima liʻiliʻi.
ʻIke ʻia nā hopena anti-aging a Vilon i ka hana GI pū kekahi, kahi i hōʻike ʻia ai ka peptide e hoʻomaikaʻi i ka hana o kekahi mau enzymes i nā ʻāpana Gi o nā ʻiole kahiko. ʻIke ʻia ka peptide e hoʻomaikaʻi i ka hana pale, pela e hoemi ai i ka ili leaky, hoʻonui i ka pale ʻana i nā maʻi, a me ka hoʻomaikaʻi ʻana i ke olakino holoʻokoʻa o ka ʻāpana GI i nā ʻiole kahiko[9]. Hōʻike ka noiʻi e kōkua ʻo Vilon i ka hoʻomaikaʻi ʻana i ka glucose a me ka glycine absorption i loko o ka ʻōpū liʻiliʻi o nā ʻiole kahiko.[10]. Hiki i kēia mau hiʻohiʻona o Vilon ke kōkua i ka mālama ʻana i nā meaʻai me ka makahiki, ma laila e hoʻomaikaʻi ai i ka maikaʻi holoʻokoʻa a hoʻonui paha i ka lōʻihi.
Ua ʻōlelo ʻo Dr. ʻO Vladimir N. Anisimov, ka mea e noiʻi ana i ka ʻelemakule a me ka ulu ʻana o ka maʻi maʻi mai ka makahiki 1970, hōʻike ʻo ia ʻo ka thymus kekahi o nā ʻāpana ʻelua (ʻo kekahi ʻo ka pineal gland) he kuleana koʻikoʻi ia i ka hoʻoponopono ʻana i ka ʻelemakule. ʻOi aku ka maikaʻi o ka thymus, ʻoi aku ka maikaʻi o mākou ma ke ʻano he kanaka. ʻae nō hoʻi, ʻO Vilon kahi peptide thymic a pili i nā pūnaewele, e like me nā lymphocytes, i hana ʻia i loko a oʻo i loko o ka thymus. Ua ʻōlelo ʻo Dr. ʻO Anisimov kahi kākoʻo kūpaʻa no ka hoʻohana ʻana i nā bioregulators peptide i ka pale ʻana i ka maʻi kanesa[11]. He hoa pili loa ia o Dr. ʻO Vladimir Khavinson.
Vilon i loko o ka puʻuwai a me nā ʻāʻī
ʻAʻole i aʻo maikaʻi ʻia ka hopena o Vilon ma ka vasculature, akā, aia kekahi mau hana e hōʻike ana he hopena maikaʻi paha ia. Hōʻike ka noiʻi ʻana i nā ʻiole e hoʻololi ʻo Vilon i ka hōʻike o ka ʻoi aku 36 nā genes like ʻole i loko o ka puʻuwai. Ke hui pū me Epithalon, lele kēia helu i 144 genes[12]. Hōʻike kēia mau ʻike i kēlā, ma ka liʻiliʻi loa, Hiki iā Vilon ke hoʻololi i nā hiʻohiʻona hōʻike gene i ka ʻōnaehana cardiovascular, he mea hiki ke hoʻomaikaʻi i ka hana hemodynamic.
I ka ʻoiaʻiʻo, noiʻi ma nā puʻupaʻa, nā ʻōpū ʻokoʻa loa, hōʻike ʻo Vilon e hoʻemi ana i ka hoʻololi ʻana i ka mea ulu-beta(1) a pēlā ka permeability o nā microvessels. ʻO ka hopena ʻoi aku ka maikaʻi o ka hemostasis i ka wā o ka hāʻule ʻana o ke kīkī, e manaʻo ana e hana ʻo Vilon, i ka ʻoiaʻiʻo, Loaʻa ka hopena maikaʻi i ka ʻōnaehana vascular[13].
Eia kekahi, ʻO ka noiʻi ʻana i nā poʻe maʻi maʻi me ka maʻi diabetes e hōʻike ana e hiki ke kōkua ʻo Vilon i ka hoʻonui ʻana i ka coagulation ma o ka hoʻonui ʻana i nā pae o nā anticoagulants kūlohelohe antithrombin III a me ka protein C aʻo ka hoʻoulu ʻana i ka fibrinolysis.[14]. ʻO ka hopena, ʻo ka liʻiliʻi o ke koko koko i loko o ka heluna kanaka e pili ana i ka clotting a me nā hopena koʻikoʻi e hiki mai ana. Kākoʻo hou kēia i ka manaʻo he hana koʻikoʻi ʻo Vilon i ka hoʻoponopono ʻana i ka ʻōnaehana vascular.
COA
HPLC
MS
ʻatikala/Literature Citation Notes
ʻO ke kumu o ka haʻi ʻana i ka ʻatikala a ka ʻepekema a me ka polopeka e hōʻoia, ʻike a mahalo i ka hana hoʻomohala piha i hana ʻia e hana i kēia noiʻi peptide. ʻAʻole kākoʻo a kākoʻo paha ka ʻepekema i ke kūʻai, kūʻai a hoʻohana paha i kēia huahana no kekahi kumu, a ʻaʻohe pili a pili paha nā MOL Changes, hōʻike ʻia a i ʻole, me ka ʻepekema.
ʻōlelo aʻo
Kuhi ʻia kēia mau huahana no nā kumu ʻepekema wale nō no ka noiʻi in vitro a ʻaʻole e hoʻohana ʻia no ke kanaka, holoholona a i ʻole nā hoʻokolohua pono ʻole, noiʻi in vitro (ʻŌlelo Lākni: i ke aniani) hana ʻia i loko o ka vitro. ʻAʻole lāʻau kēia mau huahana a ʻaʻole ʻae ʻia e ka Food and Drug Administration ma kekahi ʻāina no ka pale ʻana, lapaʻau a hoʻōla paha i kekahi maʻi maʻi, maʻi a maʻi paha. ʻO ka hoʻokomo ʻana o kēia huahana i loko o ke kanaka a i ʻole nā holoholona ma nā ʻano āpau ua pāpā loa ʻia e ke kānāwai.





